• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

蛋白质异戊二烯化:酶、治疗方法及生物技术应用

Protein prenylation: enzymes, therapeutics, and biotechnology applications.

作者信息

Palsuledesai Charuta C, Distefano Mark D

机构信息

Department of Chemistry, University of Minnesota , Minneapolis, Minnesota 55455, United States.

出版信息

ACS Chem Biol. 2015 Jan 16;10(1):51-62. doi: 10.1021/cb500791f. Epub 2014 Dec 8.

DOI:10.1021/cb500791f
PMID:25402849
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4301080/
Abstract

Protein prenylation is a ubiquitous covalent post-translational modification found in all eukaryotic cells, comprising attachment of either a farnesyl or a geranylgeranyl isoprenoid. It is essential for the proper cellular activity of numerous proteins, including Ras family GTPases and heterotrimeric G-proteins. Inhibition of prenylation has been extensively investigated to suppress the activity of oncogenic Ras proteins to achieve antitumor activity. Here, we review the biochemistry of the prenyltransferase enzymes and numerous isoprenoid analogs synthesized to investigate various aspects of prenylation and prenyltransferases. We also give an account of the current status of prenyltransferase inhibitors as potential therapeutics against several diseases including cancers, progeria, aging, parasitic diseases, and bacterial and viral infections. Finally, we discuss recent progress in utilizing protein prenylation for site-specific protein labeling for various biotechnology applications.

摘要

蛋白质异戊二烯化是一种在所有真核细胞中普遍存在的共价翻译后修饰,包括法尼基或香叶基香叶基类异戊二烯的附着。它对于许多蛋白质的正常细胞活性至关重要,包括Ras家族GTP酶和异源三聚体G蛋白。为了抑制致癌Ras蛋白的活性以实现抗肿瘤活性,人们对异戊二烯化的抑制进行了广泛研究。在这里,我们综述了异戊二烯基转移酶的生物化学以及为研究异戊二烯化和异戊二烯基转移酶的各个方面而合成的众多类异戊二烯类似物。我们还介绍了异戊二烯基转移酶抑制剂作为针对包括癌症、早衰症、衰老、寄生虫病以及细菌和病毒感染在内的多种疾病的潜在治疗药物的现状。最后,我们讨论了利用蛋白质异戊二烯化进行位点特异性蛋白质标记以用于各种生物技术应用的最新进展。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5ab1/4301080/cb8140449fbf/cb-2014-00791f_0010.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5ab1/4301080/2d0586aa24f5/cb-2014-00791f_0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5ab1/4301080/0e5e2081931d/cb-2014-00791f_0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5ab1/4301080/b7a58e23e17e/cb-2014-00791f_0005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5ab1/4301080/7ea54124fee1/cb-2014-00791f_0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5ab1/4301080/ceb2233b8a46/cb-2014-00791f_0006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5ab1/4301080/7355d30582fd/cb-2014-00791f_0007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5ab1/4301080/9672ee8f2f63/cb-2014-00791f_0008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5ab1/4301080/01d1666b48fe/cb-2014-00791f_0009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5ab1/4301080/cb8140449fbf/cb-2014-00791f_0010.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5ab1/4301080/2d0586aa24f5/cb-2014-00791f_0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5ab1/4301080/0e5e2081931d/cb-2014-00791f_0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5ab1/4301080/b7a58e23e17e/cb-2014-00791f_0005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5ab1/4301080/7ea54124fee1/cb-2014-00791f_0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5ab1/4301080/ceb2233b8a46/cb-2014-00791f_0006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5ab1/4301080/7355d30582fd/cb-2014-00791f_0007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5ab1/4301080/9672ee8f2f63/cb-2014-00791f_0008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5ab1/4301080/01d1666b48fe/cb-2014-00791f_0009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5ab1/4301080/cb8140449fbf/cb-2014-00791f_0010.jpg

相似文献

1
Protein prenylation: enzymes, therapeutics, and biotechnology applications.蛋白质异戊二烯化:酶、治疗方法及生物技术应用
ACS Chem Biol. 2015 Jan 16;10(1):51-62. doi: 10.1021/cb500791f. Epub 2014 Dec 8.
2
Using inhibitors of prenylation to block localization and transforming activity.使用异戊二烯化抑制剂来阻断定位和转化活性。
Methods Enzymol. 2006;407:575-97. doi: 10.1016/S0076-6879(05)07046-1.
3
Protein Prenyltransferases and Their Inhibitors: Structural and Functional Characterization.蛋白异戊烯基转移酶及其抑制剂:结构与功能特征。
Int J Mol Sci. 2022 May 12;23(10):5424. doi: 10.3390/ijms23105424.
4
Exploring the biochemistry of the prenylome and its role in disease through proteomics: progress and potential.通过蛋白质组学探索异戊二烯化蛋白质组的生物化学及其在疾病中的作用:进展与潜力
Expert Rev Proteomics. 2017 Jun;14(6):515-528. doi: 10.1080/14789450.2017.1332998. Epub 2017 May 26.
5
Isoprenoids and protein prenylation: implications in the pathogenesis and therapeutic intervention of Alzheimer's disease.类异戊二烯和蛋白质的类异戊二烯化:在阿尔茨海默病发病机制和治疗干预中的意义。
Crit Rev Biochem Mol Biol. 2018 Jun;53(3):279-310. doi: 10.1080/10409238.2018.1458070.
6
Protein prenyltransferases: anchor size, pseudogenes and parasites.蛋白质异戊二烯基转移酶:锚定大小、假基因与寄生虫。
Biol Chem. 2003 Jul;384(7):977-89. doi: 10.1515/BC.2003.110.
7
Evaluation of farnesyl:protein transferase and geranylgeranyl:protein transferase inhibitor combinations in preclinical models.法尼基蛋白转移酶和香叶基香叶基蛋白转移酶抑制剂组合在临床前模型中的评估
Cancer Res. 2001 Dec 15;61(24):8758-68.
8
Caged protein prenyltransferase substrates: tools for understanding protein prenylation.笼形蛋白异戊二烯基转移酶底物:理解蛋白质异戊二烯化的工具。
Chem Biol Drug Des. 2008 Sep;72(3):171-81. doi: 10.1111/j.1747-0285.2008.00698.x.
9
Structure, catalysis, and inhibition mechanism of prenyltransferase. prenyltransferase 的结构、催化和抑制机制。
IUBMB Life. 2021 Jan;73(1):40-63. doi: 10.1002/iub.2418. Epub 2020 Nov 27.
10
Novel prenyltransferase enzymes as a tool for flavonoid prenylation.新型异戊烯基转移酶作为黄酮类化合物异戊烯基化的工具。
Trends Pharmacol Sci. 2005 Dec;26(12):606-8. doi: 10.1016/j.tips.2005.09.012. Epub 2005 Oct 17.

引用本文的文献

1
In Vitro synergy of Farnesyltransferase inhibitors in combination with colistin against ESKAPE bacteria.法尼基转移酶抑制剂与黏菌素联合对ESKAPE细菌的体外协同作用
PLoS One. 2025 Sep 5;20(9):e0331440. doi: 10.1371/journal.pone.0331440. eCollection 2025.
2
The Cellular and Mitochondrial Consequences of Mevalonate Pathway Inhibition by Nitrogen-Containing Bisphosphonates: A Narrative Review.含氮双膦酸盐对甲羟戊酸途径抑制的细胞和线粒体后果:一篇叙述性综述
Pharmaceuticals (Basel). 2025 Jul 11;18(7):1029. doi: 10.3390/ph18071029.
3
Iridium-Catalyzed Regio- and Enantioselective Reverse Prenylation of Tryptamines and Other 3-Substituted Indoles.

本文引用的文献

1
Unraveling the Catalytic Pathway of Metalloenzyme Farnesyltransferase through QM/MM Computation.通过量子力学/分子力学计算揭示金属酶法尼基转移酶的催化途径。
J Chem Theory Comput. 2009 Jun 9;5(6):1657-66. doi: 10.1021/ct8004722.
2
Prenyltransferase Inhibitors: Treating Human Ailments from Cancer to Parasitic Infections.异戊烯基转移酶抑制剂:治疗从癌症到寄生虫感染的人类疾病。
Medchemcomm. 2013 Mar;4(3):476-492. doi: 10.1039/C2MD20299A.
3
[Prenylation: from bacteria to eukaryotes].[异戊二烯化:从细菌到真核生物]
铱催化色胺及其他3-取代吲哚的区域和对映选择性反向异戊烯基化反应
J Am Chem Soc. 2025 Jul 30;147(30):26506-26517. doi: 10.1021/jacs.5c06364. Epub 2025 Jul 17.
4
Protein Prenylation in Plants: Mechanisms and Functional Implications.植物中的蛋白质异戊二烯化:机制与功能意义
Plants (Basel). 2025 Jun 9;14(12):1759. doi: 10.3390/plants14121759.
5
Impact of Mutational Status on Intracellular Effects of Cell-Permeable CaaX Peptides in Pancreatic Cancer Cells.突变状态对细胞穿透性CaaX肽在胰腺癌细胞内效应的影响
Chembiochem. 2025 May 27;26(10):e202401076. doi: 10.1002/cbic.202401076. Epub 2025 Apr 24.
6
Targeting fungal lipid synthesis for antifungal drug development and potentiation of contemporary antifungals.以真菌脂质合成作为抗真菌药物研发及增强现有抗真菌药物效果的靶点。
NPJ Antimicrob Resist. 2025 Apr 12;3(1):27. doi: 10.1038/s44259-025-00093-4.
7
Design and Evaluation of Bivalent K-Ras Inhibitors That Target the CAAX Binding Site and the Acidic Surface of Farnesyltransferase and Geranylgeranyltransferase I.靶向法尼基转移酶和香叶基香叶基转移酶I的CAAX结合位点和酸性表面的二价K-Ras抑制剂的设计与评估。
Chemistry. 2025 May 14;31(27):e202500306. doi: 10.1002/chem.202500306. Epub 2025 Apr 28.
8
Molecular mechanisms underlying the effects of statins on bone metabolism: an evolving paradigm of statins delivery modalities for bone regeneration.他汀类药物对骨代谢影响的分子机制:骨再生中他汀类药物递送方式的不断演变模式。
Pharmacol Rep. 2025 Jun;77(3):624-644. doi: 10.1007/s43440-025-00716-7. Epub 2025 Apr 1.
9
Design of a Highly Active Peptide Inhibitor of Farnesyltransferase and Its Protective Effect Against Acute Liver Failure.法尼基转移酶高活性肽抑制剂的设计及其对急性肝衰竭的保护作用
Drug Des Devel Ther. 2025 Mar 13;19:1909-1926. doi: 10.2147/DDDT.S505541. eCollection 2025.
10
Regulation of Adaptive Immunity by Lipid Post-translational Modifications.脂质翻译后修饰对适应性免疫的调控
Immune Netw. 2025 Feb 18;25(1):e11. doi: 10.4110/in.2025.25.e11. eCollection 2025 Feb.
Mol Biol (Mosk). 2013 Sep-Oct;47(5):717-30.
4
Engineering protein farnesyltransferase for enzymatic protein labeling applications.用于酶促蛋白质标记应用的工程化蛋白质法尼基转移酶。
Bioconjug Chem. 2014 Jul 16;25(7):1203-12. doi: 10.1021/bc500240p. Epub 2014 Jul 2.
5
Synthesis of site-specific DNA-protein conjugates and their effects on DNA replication.位点特异性DNA-蛋白质缀合物的合成及其对DNA复制的影响。
ACS Chem Biol. 2014 Aug 15;9(8):1860-8. doi: 10.1021/cb5001795. Epub 2014 Jun 26.
6
Sandwich antibody arrays using recombinant antibody-binding protein L.使用重组抗体结合蛋白L的夹心抗体阵列。
Langmuir. 2014 Jun 10;30(22):6629-35. doi: 10.1021/la500822w. Epub 2014 May 30.
7
Rapid analysis of protein farnesyltransferase substrate specificity using peptide libraries and isoprenoid diphosphate analogues.利用肽库和类异戊二烯二磷酸类似物快速分析蛋白质法尼基转移酶的底物特异性
ACS Chem Biol. 2014 Aug 15;9(8):1726-35. doi: 10.1021/cb5002312. Epub 2014 Jun 5.
8
A combination of metabolic labeling and 2D-DIGE analysis in response to a farnesyltransferase inhibitor facilitates the discovery of new prenylated proteins.结合代谢标记和二维差异凝胶电泳分析来响应法尼基转移酶抑制剂,有助于发现新的异戊二烯化蛋白。
Mol Biosyst. 2014 May;10(5):1094-103. doi: 10.1039/c3mb70593e.
9
Diazirine-containing photoactivatable isoprenoid: synthesis and application in studies with isoprenylcysteine carboxyl methyltransferase.含重氮丙啶的光可活化类异戊二烯:合成及其在异戊烯基半胱氨酸羧基甲基转移酶研究中的应用
J Org Chem. 2014 Mar 7;79(5):1971-8. doi: 10.1021/jo402600b. Epub 2014 Feb 20.
10
Regio- and chemoselective immobilization of proteins on gold surfaces.在金表面上进行区域和化学选择性的蛋白质固定化。
Bioconjug Chem. 2014 Feb 19;25(2):269-75. doi: 10.1021/bc400413d. Epub 2014 Feb 4.